Accéder au contenu
Merck

Genome-wide DNA methylation and RNA expression differences correlate with invasiveness in melanoma cell lines.

Epigenomics (2021-03-31)
Jyoti Motwani, Euan J Rodger, Peter A Stockwell, Bruce C Baguley, Erin C Macaulay, Michael R Eccles
RÉSUMÉ

Aims & objectives: The aim of this study was to investigate the role of DNA methylation in invasiveness in melanoma cells. Materials & methods: The authors carried out genome-wide transcriptome (RNA sequencing) and reduced representation bisulfite sequencing methylome profiling between noninvasive (n = 4) and invasive melanoma cell lines (n = 5). Results: The integration of differentially expressed genes and differentially methylated fragments (DMFs) identified 12 DMFs (two in AVPI1, one in HMG20B, two in BCL3, one in NTSR1, one in SYNJ2, one in ROBO2 and four in HORMAD2) that overlapped with either differentially expressed genes (eight DMFs and six genes) or cis-targets of lncRNAs (five DMFs associated with cis-targets and four differentially expressed lncRNAs). Conclusions: DNA methylation changes are associated with a number of transcriptional differences observed in noninvasive and invasive phenotypes in melanoma.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Roche
Insulin-Transferrin-Sodium Selenite Supplement, suitable for cell culture, lyophilized, pkg of 50 mg (for 5 l medium)